InvestorsHub Logo
Followers 34
Posts 5999
Boards Moderated 0
Alias Born 03/07/2006

Re: None

Tuesday, 03/27/2007 11:44:06 AM

Tuesday, March 27, 2007 11:44:06 AM

Post# of 15810
2 interesting points from today PR...

Over 35 million patients suffer from dry AMD in the developed world, yet there are currently no available treatment options. In some patients, dry AMD progresses to wet AMD, a leading cause of adult blindness."

"Froptix Corporation has licensed exclusive rights to technology developed at the University of Florida in Gainesville relating to small molecule therapeutics for retinal and macular degeneration. It has lead compounds for the treatment of dry AMD and retinitis pigmentosa and an extensive pipeline of additional small molecule clinical candidates.

JMO - Do your own DD.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent OPK News